Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Amortization - Intangibles (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Amortization - Intangibles for 4 consecutive years, with $306000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Amortization - Intangibles changed 0.0% to $306000.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $1.2 million, a 0.0% change, with the full-year FY2018 number at $1.2 million, changed 0.0% from a year prior.
  • Amortization - Intangibles was $306000.0 for Q1 2019 at Plus Therapeutics, roughly flat from $307000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $346000.0 in Q4 2016 to a low of $57000.0 in Q3 2016.
  • A 4-year average of $256923.1 and a median of $306000.0 in 2017 define the central range for Amortization - Intangibles.
  • Biggest YoY gain for Amortization - Intangibles was 436.84% in 2017; the steepest drop was 11.27% in 2017.
  • Plus Therapeutics' Amortization - Intangibles stood at $346000.0 in 2016, then fell by 11.27% to $307000.0 in 2017, then changed by 0.0% to $307000.0 in 2018, then decreased by 0.33% to $306000.0 in 2019.
  • Per Business Quant, the three most recent readings for PSTV's Amortization - Intangibles are $306000.0 (Q1 2019), $307000.0 (Q4 2018), and $306000.0 (Q3 2018).